Eli Lilly & Co. (LLY)
931.09
+4.03
(+0.43%)
USD |
NYSE |
Apr 07, 16:00
942.22
+11.13
(+1.20%)
After-Hours: 20:00
Eli Lilly Cash from Investing (TTM) : -10.97B for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Regeneron Pharmaceuticals, Inc. | -629.10M |
| Viking Therapeutics, Inc. | 341.39M |
| Apellis Pharmaceuticals, Inc. | -0.313M |
| Arcellx, Inc. | 86.30M |
| Moderna, Inc. | 1.946B |